Our business development activities are integral to translating cutting-edge research into real-world solutions for patients with neurological and mental health disorders. We not only dedicate our resources to nurturing research projects for 3 to 5 years, but also guide them toward their next phase of growth.

Once our research projects reach a maturity stage, we help them follow the most efficient path to reach clinics and society at large. Our team focuses on ensuring their long-term clinical impact and commercial success—either evolving into start-up companies or forming partnerships with established industry leaders for further investment and development.

To increase the robustness of our portfolio, and ensure that powerful neurotechnology is reaching the market, we also directly invest in promising companies. We provide support through every stage of development, from funding, mentorship, and business framework creation, to the building of an investor network.

Partnering with industry and clinical leaders, creating startups and licensing to larger organizations are key to bringing technical inventions to patients around the world, and elevating the healthcare ecosystem.